SS-31 10mg
SS-31 (Elamipretide/Bendavia) is a mitochondria-targeted tetrapeptide that selectively concentrates in the inner mitochondrial membrane, binding to cardiolipin. Research demonstrates improvement in mitochondrial bioenergetics, reduction of reactive oxygen species, and protection against ischemia-reperfusion injury. Clinical trials are underway for Barth syndrome and heart failure.
Sequence
D-Arg-Dmt-Lys-Phe-NH2
Market avg: $69.99 — save 40%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-SS31-2026-001
Purity
99.1%
Method
HPLC-MS
Batch
SS31-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Storage Requirements
Lyophilized
2-8°C, protect from light
Reconstituted
2-8°C, use within 21 days
Mitochondria-targeted peptide. Reconstitute with bacteriostatic water.
Published Research
2 peer-reviewed studies
Optimizing mitochondria-targeted peptide antioxidants: SS-31 and its analogs
Szeto HH. — Annals of the New York Academy of Sciences, 2006
Original characterization of SS-31 mitochondrial targeting and antioxidant mechanisms.
Elamipretide (SS-31) treatment attenuates age-associated post-translational modifications of heart proteins
Dai DF, Chen T, Szeto H, et al. — GeroScience, 2017
Study of SS-31 effects on age-related cardiac protein modifications and mitochondrial function.
Related Products
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.